Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Data comparing various second-line treatments for asthma with subjective and objective assessment are lacking. This study aimed to compare the efficacy and safety of montelukast, doxofylline, and tiotropium with a low-dose budesonide in patients with mild to moderate persistent asthma.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Ther

Title: Clinical therapeutics

ISSN (Electronic): 1879-114X

ISSN (Print): 0149-2918

Publication date (Electronic): Feb 1 2015

Volume: 37

Issue: 2

Affiliations

[1 ] Department of Pharmacy Practice, Faculty of Pharmacy, Sri Ramachandra University, Porur, Chennai, Tamil Nadu, India.

[2 ] Department of Pulmonary Medicine, SRM Medical College Hospital and Research Centre, SRM University, Tamil Nadu, India.

[3 ] Interdisciplinary School of Indian System of Medicine, SRM University, Tamil Nadu, India. Electronic address: ilangok67@gmail.com.

Article

Publisher Item ID: S0149-2918(14)00828-5

DOI: 10.1016/j.clinthera.2014.12.008

PubMed ID: 25577543

SO-VID: 90b9409f-d80a-4403-bfb1-f540c9a5edc6

History

Keywords: budesonide,doxofylline,formoterol,montelukast, tiotropium

Data availability:

Keywords: budesonide, doxofylline, formoterol, montelukast, tiotropium

Comments

Comment on this article

scite_

Cited by 7

See all cited by

- Version 1